Genetic and Neuroendocrine Control of Behavioral Systems
行为系统的遗传和神经内分泌控制
基本信息
- 批准号:7246608
- 负责人:
- 金额:$ 28.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistApomorphineBehaviorBehavior ControlBehavioralBindingBiological ModelsBrainClinicClinical TreatmentComplexDiseaseDopamineDopamine AgonistsDopamine AntagonistsDopamine D1 ReceptorDopamine ReceptorDrug usageEjaculationEndocrineEngineeringEnvironmentEnzymesErectile dysfunctionEstradiolEstrogen Receptor alphaEstrogensExposure toFemaleGenesGeneticGenetic TranscriptionGenetically Engineered MouseGenomicsHormone ReceptorHormonesHumanIndividualInfusion proceduresKnockout MiceLaboratoriesLife ExperienceMapsMasculineMedialMediatingMicrodialysisModelingModificationMusMutant Strains MiceMutationNeural PathwaysNeurobiologyNeurosecretory SystemsNeurotransmittersNitric OxideNitric Oxide DonorsNitric Oxide SynthaseOutcomePathway interactionsPatientsPharmaceutical PreparationsPharmacologyPhenotypePreoptic AreasProgesterone ReceptorsRecording of previous eventsResourcesRoleSex BehaviorSexual DysfunctionSocial BehaviorSystemTechnical ExpertiseTestingTimeTreatment FactorTreatment outcomeVariantWorkbasedeviantexperienceextracellularfiber cellgene functionhormone therapyin vivoinnovationmalemenmouse genomenovelprogramsreceptorrelating to nervous systemresponsesexsocialsteroid hormone receptor
项目摘要
DESCRIPTION (provided by applicant): The long term objective of these studies is to understand how genes, hormones, and environment interact and ultimately control complex social behaviors. The human and mouse genomes have been sequenced. Human endocrine mutations are common in the clinic, and engineered and sponateous mouse mutants along with hormone receptors are available for many of the enzymes that regulate hormone sythesis. Thus, the genetic bases of major hormones and their receptors are well known. But the inverse relationship, how behavior affects gene function, is relatively unexplored. The studies proposed here will dissect gene, hormone, and behavior interactions and elucidate the mechanisms by which the steroid hormone receptor, estrogen receptor alpha affects the evolutionarily essential and conserved set of behaviors that consititute male sexual behavior. We will use central administration of dopamine to activate sexual behavior in male mice lacking a functional estrogen receptor alpha gene, and we will ask if sexual experience can compensate for exogenous dopamine. In vivo microdialysis will be conducted to determine if estrogen and/or the gaseous neurotransmitter, nitric oxide, can stimulate dopamine release in the medial preoptic area. In addition, we will ask if the estrogen receptor alpha is required for female-induced dopamine release in the brain and if this is modified by sex experience. To pinpoint which dopamine receptor is essential for this behavior we will use dopamine receptor agonists and antagonists, appropriate doamine receptor knockout mice, and the progestin receptor knockout mouse to ask if dopamine acts via the unoccupied progestin receptor to initiate sexual behavior in naive males. The innovative aspects of this program include the use of pharmacology, knockout mice, and life experiences as factors that affect gene actions. Sexual dysfunctions including premature ejaculation and erectile disorders are common in men. Our understanding of the neurobiology of these disorders is limited, and the interactions between sexual experiential factors and treatment are unknown. Several clinical treatments for erectile disorder in men incorporate the use of drugs we will use for our work; nitric oxide donors and dopamine agonists. The information we will generate may help explain why patients undergoing similar drug or hormone therapies often display wide individual variations in treatment outcomes.
这些研究的长期目标是了解基因、激素和环境如何相互作用并最终控制复杂的社会行为。人类和小鼠的基因组已经测序。人类内分泌突变在临床上是常见的,并且工程化的和自发的小鼠突变体沿着激素受体可用于调节激素合成的许多酶。因此,主要激素及其受体的遗传基础是众所周知的。但是相反的关系,行为如何影响基因功能,是相对未探索的。本文提出的研究将剖析基因、激素和行为的相互作用,并阐明类固醇激素受体、雌激素受体α影响进化上必要的和保守的行为的机制,这些行为构成了男性性行为。我们将使用多巴胺的中枢给药来激活缺乏功能性雌激素受体α基因的雄性小鼠的性行为,我们将询问性经验是否可以补偿外源性多巴胺。将进行体内微透析以确定雌激素和/或气态神经递质一氧化氮是否可以刺激内侧视前区的多巴胺释放。此外,我们还将询问雌激素受体α是否是女性诱导的多巴胺在大脑中释放所必需的,以及这是否会被性经验所改变。为了确定哪种多巴胺受体对这种行为至关重要,我们将使用多巴胺受体激动剂和拮抗剂,适当的多胺受体敲除小鼠,以及多巴胺受体敲除小鼠,以询问多巴胺是否通过未占据的多巴胺受体来启动幼稚雄性的性行为。该计划的创新方面包括使用药理学,基因敲除小鼠和生活经验作为影响基因作用的因素。性功能障碍包括早泄和勃起障碍在男性中很常见。我们对这些疾病的神经生物学的理解是有限的,性经验因素和治疗之间的相互作用是未知的。一些男性勃起障碍的临床治疗包括使用我们将用于我们工作的药物;一氧化氮供体和多巴胺激动剂。我们将产生的信息可能有助于解释为什么接受类似药物或激素治疗的患者在治疗结果上往往表现出广泛的个体差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emilie F. Rissman其他文献
Sex/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect
物质使用障碍发展的时间过程中的性别差异:关注压缩效应
- DOI:
10.1124/pharmrev.121.000361 - 发表时间:
2023-03-01 - 期刊:
- 影响因子:17.300
- 作者:
Eleanor Blair Towers;Ivy L. Williams;Emaan I. Qillawala;Emilie F. Rissman;Wendy J. Lynch - 通讯作者:
Wendy J. Lynch
Detection of cuckoldry in ring doves
- DOI:
10.1016/s0003-3472(83)80065-7 - 发表时间:
1983-05-01 - 期刊:
- 影响因子:
- 作者:
Emilie F. Rissman - 通讯作者:
Emilie F. Rissman
Aromatase Deletion Accelerates Female Experimental Abdominal Aortic Aneurysm Formation
- DOI:
10.1016/j.jvs.2013.07.042 - 发表时间:
2013-10-01 - 期刊:
- 影响因子:
- 作者:
William Forrest Johnston;Gang Su;Morgan Salmon;Guanyi Lu;Emilie F. Rissman;Gorav Ailawadi;Gilbert Rivers Upchurch - 通讯作者:
Gilbert Rivers Upchurch
Emilie F. Rissman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emilie F. Rissman', 18)}}的其他基金
Transgenerational actions of the endocrine disrupting compound Bisphenol A
内分泌干扰物双酚 A 的跨代作用
- 批准号:
8694282 - 财政年份:2014
- 资助金额:
$ 28.92万 - 项目类别:
Transgenerational actions of the endocrine disrupting compound Bisphenol A
内分泌干扰物双酚 A 的跨代作用
- 批准号:
9079470 - 财政年份:2014
- 资助金额:
$ 28.92万 - 项目类别:
Transgenerational actions of the endocrine disrupting compound Bisphenol A
内分泌干扰物双酚 A 的跨代作用
- 批准号:
8870353 - 财政年份:2014
- 资助金额:
$ 28.92万 - 项目类别:
Transgenerational actions of the endocrine disrupting compound Bisphenol A
内分泌干扰物双酚 A 的跨代作用
- 批准号:
9230380 - 财政年份:2014
- 资助金额:
$ 28.92万 - 项目类别:
Genetic and cellular sex differences in cerebellum
小脑的遗传和细胞性别差异
- 批准号:
8445000 - 财政年份:2012
- 资助金额:
$ 28.92万 - 项目类别:
Genetic and cellular sex differences in cerebellum
小脑的遗传和细胞性别差异
- 批准号:
8543778 - 财政年份:2012
- 资助金额:
$ 28.92万 - 项目类别:
Sex Chromosomes, Epigenetics, and Neurobehavioral Disease
性染色体、表观遗传学和神经行为疾病
- 批准号:
8067079 - 财政年份:2009
- 资助金额:
$ 28.92万 - 项目类别:
Sex Chromosomes, Epigenetics, and Neurobehavioral Disease
性染色体、表观遗传学和神经行为疾病
- 批准号:
7713062 - 财政年份:2009
- 资助金额:
$ 28.92万 - 项目类别:
Sex Chromosomes, Epigenetics, and Neurobehavioral Disease
性染色体、表观遗传学和神经行为疾病
- 批准号:
7900841 - 财政年份:2009
- 资助金额:
$ 28.92万 - 项目类别:
Sex chromosome effects on neural and behavioral differentiation
性染色体对神经和行为分化的影响
- 批准号:
7989395 - 财政年份:2007
- 资助金额:
$ 28.92万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 28.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 28.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 28.92万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 28.92万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 28.92万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 28.92万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 28.92万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 28.92万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 28.92万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 28.92万 - 项目类别: